These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9384674)
21. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist. Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352 [TBL] [Abstract][Full Text] [Related]
22. Causal links between brain cytokines and experimental febrile convulsions in the rat. Heida JG; Pittman QJ Epilepsia; 2005 Dec; 46(12):1906-13. PubMed ID: 16393156 [TBL] [Abstract][Full Text] [Related]
23. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-1, characterization of the molecule, functional activity, and clinical implications. Brazel D; Nakanishi S; Oster W Biotechnol Ther; 1991; 2(3-4):241-67. PubMed ID: 1845129 [TBL] [Abstract][Full Text] [Related]
25. Biologic basis for interleukin-1 in disease. Dinarello CA Blood; 1996 Mar; 87(6):2095-147. PubMed ID: 8630372 [TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor 1-induced interleukin-1 receptor II overrides the activity of interleukin-1 and controls the homeostasis of the extracellular matrix of cartilage. Wang J; Elewaut D; Veys EM; Verbruggen G Arthritis Rheum; 2003 May; 48(5):1281-91. PubMed ID: 12746901 [TBL] [Abstract][Full Text] [Related]
27. [Mechanism of the production and the action of IL-1]. Kasahara T; Mukaida N Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1140-8. PubMed ID: 1831276 [No Abstract] [Full Text] [Related]
28. Interleukin-1 and bone metabolism: a review. Tatakis DN J Periodontol; 1993 May; 64(5 Suppl):416-31. PubMed ID: 8315564 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-1 and its inhibitors: implications for disease biology and therapy. Estrov Z; Kurzrock R; Talpaz M Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574 [TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of the effect of interleukin-1 inhibitor activators]. Ramić Z; Stosić-Grujicić S; Kataranovski M; Lazić M; Dimković N; Mostarica-Stojković M; Petronić V; Simić MM; Lukić ML Glas Srp Akad Nauka Med; 1994; (44):21-33. PubMed ID: 7590412 [TBL] [Abstract][Full Text] [Related]
32. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1). Palmer G; Trolliet S; Talabot-Ayer D; Mézin F; Magne D; Gabay C Cytokine; 2005 Jul; 31(2):153-60. PubMed ID: 15923123 [TBL] [Abstract][Full Text] [Related]
33. Autocrine regulation of collagenase 3 (matrix metalloproteinase 13) during osteoarthritis. Shlopov BV; Gumanovskaya ML; Hasty KA Arthritis Rheum; 2000 Jan; 43(1):195-205. PubMed ID: 10643716 [TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
35. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959 [TBL] [Abstract][Full Text] [Related]
36. Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer. Kopp WC; Urba WJ; Rager HC; Alvord WG; Oppenheim JJ; Smith JW; Longo DL Clin Cancer Res; 1996 Mar; 2(3):501-6. PubMed ID: 9816196 [TBL] [Abstract][Full Text] [Related]
37. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437 [TBL] [Abstract][Full Text] [Related]
38. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. François M; Richette P; Tsagris L; Fitting C; Lemay C; Benallaoua M; Tahiri K; Corvol MT Arthritis Rheum; 2006 Apr; 54(4):1233-45. PubMed ID: 16572457 [TBL] [Abstract][Full Text] [Related]
39. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413 [TBL] [Abstract][Full Text] [Related]
40. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils. Xing L; Remick DG Shock; 2003 Jul; 20(1):10-6. PubMed ID: 12813362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]